GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Revium Recovery Inc (OTCPK:RVRC) » Definitions » Notes Receivable

RVRC (Revium Recovery) Notes Receivable : $0.00 Mil (As of . 20)


View and export this data going back to 2009. Start your Free Trial

What is Revium Recovery Notes Receivable?

Revium Recovery's Notes Receivable for the quarter that ended in . 20 was $0.00 Mil.


Revium Recovery Notes Receivable Historical Data

The historical data trend for Revium Recovery's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revium Recovery Notes Receivable Chart

Revium Recovery Annual Data
Trend
Notes Receivable

Revium Recovery Semi-Annual Data
Notes Receivable

Revium Recovery Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Revium Recovery Notes Receivable Related Terms

Thank you for viewing the detailed overview of Revium Recovery's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Revium Recovery Business Description

Traded in Other Exchanges
N/A
Address
10 HaMenofim Street, Herzliya, ISR, 4672561
Revium Recovery Inc is focused on developing cutting-edge nano-medicines to deliver treatment solutions for diseases with limited or no effective medical options. LipoVation has exclusive license rights to develop and market a novel technology related to Nano-Liposomal Particles (NLP) based medicines, including: novel formulation of a potent antibiotic which shows promise in combating several life-threatening antibiotic-resistant bacteria which currently have no available treatment, Novel adjuvant to cancer therapies, and novel immunization approach based on Liposomal Protein-Loaded Technology (LPLT).

Revium Recovery Headlines